Infusion Therapy

Acon Investments’ BioMatrix Is up for Sale

A sale process has kicked off for BioMatrix, a private equity-backed national provider of specialty pharmacy and home infusion services, according to four sources familiar with the matter. Cantor Fitzgerald is running the process, which is in its early stages, sources said. ACON Investments, a Washington, DC-based international mid-market private equity firm, completed its acquisition

Acon Investments’ BioMatrix Is up for Sale Read More »

FlexCare Infusion Centers Partners with River Cities Capital

FlexCare Infusion Centers, a patient-first platform of ambulatory infusion centers, announced a partnership with River Cities Capital, a healthcare-focused growth equity firm, to accelerate FlexCare’s regional expansion across Oklahoma and Alabama. In conjunction, FlexCare announced the opening of three new centers: two in Tulsa and one in Birmingham. FlexCare currently operates five centers throughout Oklahoma

FlexCare Infusion Centers Partners with River Cities Capital Read More »

Option Care Hungry for M&A

With a tuck-in acquisition in the Southeast, a new state-of-the-art facility in Chicago and new therapies added to its chronic care portfolio, Option Care Health is laying the groundwork for sustainable growth, say company officials. Option Care announced May 6 it had paid $18.5 million for Houston-based BioCureRx, a regional provider of certain chronic care

Option Care Hungry for M&A Read More »

Scroll to Top